Royalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication. This new edition contains hundreds of royalty rates and other financial compensation benchmarks that can be used to optimize the pricing of biotechnology and pharmaceutical innovations. You’ll find updated and expanded information from past editions as well as an increased number of reported license agreements with transaction details that have been collected from well-established sources over a period of 20 years of research.

Royalty Rates for Pharmaceuticals & Biotechnology provides real-deal information for hundreds of transactions, including the technology licensed, royalty rates, license fees, and milestone payments.  And it goes well beyond the rates to provide context for each deal analyzed. This unique resource is organized into two useful sections:

• The first section covers the theory for deriving royalty rates. An overview of intellectual property value is included along with methods that can be employed to derive royalty rates: 
  • Simple Rules of Thumb
  • Industry Guidelines
  • Discounted Cash Flow Analysis
  • Risk-Adjusted Net Present Value Analysis
  • Infringement Damages Analysis
  • Comparable License Transactions
  • Investment Rate of Return Analysis
  • Relief-From-Royalty Method
• The second section of this unique report presents detailed financial information from real-world transactions. You’ll find information on the parties involved in the transactions along with a description of the technology exchanged and all financial details that could be discovered